CXCR2 and cancer: Interestingly, we found that PMN-MDSC infiltrating mesothelioma showed much lower level of CXCR2 expression than in melanoma that might explain the lack of anti-tumor effect of CXCR2 blockade, indicating that the beneficial effect of such therapy might be successful not in all cancer types.